- Filed
- Apr 23, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 179.9M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $6.82B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $6.73B |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $62M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $566M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $2.14B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $2.41B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $3.7B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $3.57B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.92B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $3.6B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $11.24B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $11.78B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $4.57B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $5.29B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $15.1B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $15.51B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 183.4M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $120M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $155M |
| Capex | Q1 2025 · Mar 31, 2024 | $78M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $775M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $3.15 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $3.16 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $413M |
| Net Income | Q1 2025 · Mar 31, 2024 | $577M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $801M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $467M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.79B |